Asthma and Respiratory Foundation NZ
Menu
Donate
Asthma and Respiratory Foundation NZ
In this section
Filter by topic:
All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases:

Surinder S. Birring, Donald M. Bushnell, Michael Baldwin, Heiko Mueller, Natalia Male, Klaus B. Rohr, Yoshikazu Inoue

2 June, 2022

NZ Respiratory Research Review Issue 201

Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era:

Jason G.E. Zelt, Jordan Sugarman, Jason Weatherald, Arun C.R. Partridge, Jiaming (Calvin) Liang, John Swiston, Nathan Brunner, George Chandy, Duncan J. Stewart, Vladimir Contreras-Dominguez, Mitesh Thakrar, Doug Helmersen, Rhea Varughese, Naushad Hirani, Fraz Umar, Rosemary Dunne, Caroyln Doyle-Cox, Julia Foxall, Lisa Mielniczuk

2 June, 2022

NZ Respiratory Research Review Issue 202

Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry:

Marius M. Hoeper, Christine Pausch, Ekkehard Grünig, Gerd Staehler, Doerte Huscher, David Pittrow, Karen M. Olsson, Carmine Dario Vizza, Henning Gall, Oliver Distler, Christian Opitz, J. Simon R. Gibbs, Marion Delcroix, H. Ardeschir Ghofrani, Stephan Rosenkranz, Da-Hee Park, Ralf Ewert, Harald Kaemmerer, Tobias J. Lange, Hans-Joachim Kabitz, Dirk Skowasch, Andris Skride, Martin Claussen, Juergen Behr, Katrin Milger, Michael Halank, Heinrike Wilkens, Hans-Jürgen Seyfarth, Matthias Held, Daniel Dumitrescu, Iraklis Tsangaris, Anton Vonk-Noordegraaf, Silvia Ulrich, Hans Klose

2 June, 2022

NZ Respiratory Research Review Issue 202

Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough:

Akio Niimi, Junpei Saito, Tadashi Kamei, Masaharu Shinkai, Hiroyuki Ishihara, Mitsuaki Machida and Sayaka Miyazaki

2 June, 2022

NZ Respiratory Research Review Issue 203

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden:

Yanina Balabanova, Bahman Farahmand, Hans Garmo, Pär Stattin, Gunnar Brobert

23 May, 2022

NZ Respiratory Research Review Issue 202

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles:

Simon Y. Graeber, Diane M. Renz, Mirjam Stahl, Sophia T. Pallenberg, Olaf Sommerburg, Lutz Naehrlich, Julian Berges, Martha Dohna, Felix C. Ringshausen, Felix Doellinger, Constanze Vitzthum, Jobst Röhmel, Christine Allomba, Susanne Hämmerling, Sandra Barth, Claudia Rückes-Nilges, Mark O. Wielpütz, Gesine Hansen, Jens Vogel-Claussen, Burkhard Tümmler, Marcus A. Mall, and Anna-Maria Dittrich

10 May, 2022

NZ Respiratory Research Review Issue 203

Effects of traditional mind–body movement therapy on chronic cardiopulmonary dyspnoea: a systematic review and meta-analysis:

Tiange Zhang, Rui Zhou, Ting Wang, Yijun Xin, Xiaohong Liu, Huiting Huang

28 April, 2022

NZ Respiratory Research Review Issue 207

Tuberculosis and COVID-19 co-infection: description of the global cohort:

The TB/COVID-19 Global Study Group. Corresponding author: Giovanni Battista Migliori

24 March, 2022

NZ Respiratory Research Review Issue 199

High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial:

Prof Rémi Coudroy, PhD Prof Jean-Pierre Frat, PhD Prof Stephan Ehrmann, PhD Prof Frédéric Pène, PhD Maxens Decavèle, MD Prof Nicolas Terzi, PhD et al.

21 March, 2022

NZ Respiratory Research Review Issue 208

The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial:

rof Harm A W M Tiddens, MD Yuxin Chen, MS Eleni-Rosalina Andrinopoulou, PhD Prof Stephanie D Davis, MD Prof Margaret Rosenfeld, MD Prof Felix Ratjen, MD et al.

11 March, 2022

NZ Respiratory Research Review Issue 203